NANCY SEAMAN: Open Payments
NPI 1588715783 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 29 payments from 12 companies in 2025. Trend: 2023 $417 · 2024 $355 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $280 |
| Novo Nordisk Inc | 2 | $204 |
| Vanda Pharmaceuticals Inc. | 8 | $198 |
| AstraZeneca Pharmaceuticals LP | 5 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $88 |
| Inspire Medical Systems, Inc. | 2 | $46 |
| Boston Scientific Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
Products named: Auvelity, FANAPT, Wegovy, AIRSUPRA, Ozempic, INSPIRE, FARXIGA, WATCHMAN Access System.
Industry payments across AL — which companies pay providers there.
